Orrick Advises Rocket Pharmaceuticals on Convertible Notes Refinancing
Our team has significant experience with high yield, investment grade and convertible notes offerings, including financing for leveraged acquisitions, as well as liability management transactions such as exchange offers, tender offers and consent solicitations. Our ongoing work with leading global companies across a wide range of industries highlights the strength of our relationships with our clients and their trust in our counsel. We also help our corporate clients with ongoing compliance with the terms of their debt securities and other indebtedness.
A key feature of our practice is our ability to advise on evolving transactions that require flexibility in selecting the best financing solution ultimately implemented. Our team coordinates seamlessly on structuring and negotiating transactions with both bank and bond financing components and can also change gears smoothly from one financing structure to another to accommodate fluctuating market conditions and pricing considerations for each individual deal. We have extensive experience in managing collateral and cross-border concerns and negotiating intercreditor issues between different classes of debt.
With a global network of offices and experience in several crucial areas of fundraising, our debt capital markets capabilities build upon the expertise of our highly rated Banking & Finance, Energy, Infrastructure and M&A and Private Equity practice groups, providing counsel on the debt capital markets components of leveraged acquisitions, financings for high impact energy and infrastructure projects and acquisitions in the technology sector and numerous other industries. Orrick has worked on numerous high profile transactions that have been recognized for their complexity and execution. Orrick routinely advises clients on complex and transformational transactions that have been recognized for their complexity and execution, including: